What You Should Know:
– Nabla, a Boston, MA-based ambient AI assistant for healthcare professionals, announced today the initial close of a $24M Series B funding round led by Cathay Innovation, with participation from ZEBOX Ventures.
– The latest round of funding brings Nabla’s total funding to over $43M and fuels its mission to revolutionize healthcare delivery by empowering clinicians and improving patient care.
Easing the Burden of EHRs:
Clinicians often cite managing the electronic health record (EHR) as their biggest stressor, adding hours of tedious documentation to their workload. Nabla tackles clinicians’ biggest pain point: the electronic health record (EHR). Clinical documentation takes up a staggering six hours per week, stealing valuable time from patient care. Nabla Copilot, powered by AI, tackles this challenge with:
- AI-powered note generation: Creates accurate and concise notes in real-time, reducing documentation time significantly.
- Medical coding recognition: Automatically identifies and codes diagnoses and procedures, streamlining billing and reimbursement.
- Seamless EHR integration: Works seamlessly with existing EHR platforms, minimizing disruption to workflows.
Nabla caters to both small practices and large health systems, partnering with EHR platforms for seamless integration and prioritizing privacy, accuracy, and speed. Their proprietary Large Language Models (LLMs) and Speech-to-Text (STT) technologies, developed by former Facebook AI Research engineers, ensure cutting-edge performance and security.
95% accuracy
Launched in March 2023, Nabla Copilot has experienced rapid growth with +20,000 providers who have already adopted the solution for its accessibility, accuracy, and speed, and have helped build Copilot to better serve the provider community’s needs. To date, more than 3 million consultations were conducted through Nabla Copilot annually. The solution boasts 95% accuracy in generated notes, requiring minimal edits and time savings of up to 50% in documentation tasks.
“This fundraise allows us to continue delivering on our vision to build the premier ambient AI assistant that will allow clinicians to experience the joy of practicing again,” says Alex Lebrun, Nabla’s co-founder and CEO. “Clinical documentation is just the beginning. Health systems are eager to leverage AI across the entire spectrum of healthcare, and we’re ready to be their partner.”
